ArticleThe American journal of case reports2025
Tricuspid Valve Infective Endocarditis with Severe Tricuspid Regurgitation.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Tricuspid valve infective endocarditis (TVIE) is a serious condition commonly associated with intravenous drug use (IVDU). It frequently leads to complications such as severe tricuspid regurgitation, septic embolization, and vegetation growth requiring surgical intervention. This case highlights the complexities of treating TVIE in an IVDU patient and emphasizes the need for multidisciplinary care strategies. CASE REPORT A man in his early 40s with a history of IVDU and hepatitis C presented with generalized chest pain, productive cough, fevers, and left groin swelling. Blood cultures confirmed methicillin-sensitive Staphylococcus aureus bacteremia, and echocardiography revealed a large (19 mm) vegetation on the tricuspid valve with severe tricuspid regurgitation and evidence of right ventricular overload. Despite an initial course of intravenous antibiotics, the patient exhibited poor adherence to treatment and discharged against medical advice. He returned with worsening symptoms, persistent bacteremia, and progressive vegetation growth, necessitating surgical intervention. However, due to concerns regarding postoperative compliance, compounded by the patient's fear of surgical risks and ongoing substance use, he refused surgery after initially consenting, resulting in loss to follow-up. CONCLUSIONS This case underscores the challenges of managing TVIE in the context of IVDU, particularly regarding treatment adherence and continuity of care. It highlights the importance of early multidisciplinary intervention, including addiction support services, supervised antimicrobial therapy, and patient-centered discharge planning. Future strategies should focus on integrating medical and social interventions to improve patient outcomes and reduce recurrent infections in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.